BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 23051178)

  • 1. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome.
    Lindfors P; Ljótsson B; Bjornsson E; Abrahamsson H; Simrén M
    Neurogastroenterol Motil; 2013 Feb; 25(2):169-e86. PubMed ID: 23051178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials.
    Lindfors P; Unge P; Arvidsson P; Nyhlin H; Björnsson E; Abrahamsson H; Simrén M
    Am J Gastroenterol; 2012 Feb; 107(2):276-85. PubMed ID: 21971535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome.
    Smith GD
    J Clin Nurs; 2006 Jun; 15(6):678-84. PubMed ID: 16684163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome.
    Gonsalkorale WM; Toner BB; Whorwell PJ
    J Psychosom Res; 2004 Mar; 56(3):271-8. PubMed ID: 15046962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trial of brief intervention with biofeedback and hypnotherapy in patients with refractory irritable bowel syndrome.
    Dobbin A; Dobbin J; Ross SC; Graham C; Ford MJ
    J R Coll Physicians Edinb; 2013; 43(1):15-23. PubMed ID: 23516685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome.
    Lindfors P; Unge P; Nyhlin H; Ljótsson B; Björnsson ES; Abrahamsson H; Simrén M
    Scand J Gastroenterol; 2012 Apr; 47(4):414-20. PubMed ID: 22339617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on gastrointestinal transit and antroduodenojejunal manometry after gut-directed hypnotherapy in irritable bowel syndrome (IBS).
    Lindfors P; Törnblom H; Sadik R; Björnsson ES; Abrahamsson H; Simrén M
    Scand J Gastroenterol; 2012 Dec; 47(12):1480-7. PubMed ID: 23094932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial.
    Roberts L; Wilson S; Singh S; Roalfe A; Greenfield S
    Br J Gen Pract; 2006 Feb; 56(523):115-21. PubMed ID: 16464325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial.
    Moser G; Trägner S; Gajowniczek EE; Mikulits A; Michalski M; Kazemi-Shirazi L; Kulnigg-Dabsch S; Führer M; Ponocny-Seliger E; Dejaco C; Miehsler W
    Am J Gastroenterol; 2013 Apr; 108(4):602-9. PubMed ID: 23419384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
    Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
    Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life.
    Böhn L; Störsrud S; Törnblom H; Bengtsson U; Simrén M
    Am J Gastroenterol; 2013 May; 108(5):634-41. PubMed ID: 23644955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis.
    Devenney J; Hasan SS; Morris J; Whorwell PJ; Vasant DH
    Aliment Pharmacol Ther; 2024 Jan; 59(2):269-277. PubMed ID: 37927144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group hypnotherapy for irritable bowel syndrome with long-term follow-up.
    Gerson CD; Gerson J; Gerson MJ
    Int J Clin Exp Hypn; 2013; 61(1):38-54. PubMed ID: 23153384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nurse-Administered, Gut-Directed Hypnotherapy in IBS: Efficacy and Factors Predicting a Positive Response.
    Lövdahl J; Ringström G; Agerforz P; Törnblom H; Simrén M
    Am J Clin Hypn; 2015 Jul; 58(1):100-14. PubMed ID: 26046719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement.
    Whitehead WE; Palsson OS; Levy RL; Feld AD; VonKorff M; Turner M
    Am J Gastroenterol; 2006 May; 101(5):1057-65. PubMed ID: 16573774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structured patient education is superior to written information in the management of patients with irritable bowel syndrome: a randomized controlled study.
    Ringström G; Störsrud S; Posserud I; Lundqvist S; Westman B; Simrén M
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):420-8. PubMed ID: 19923998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial.
    Hoekman DR; Vlieger AM; Stokkers PC; Mahhmod N; Rietdijk S; de Boer NK; de Meij TG; Frankenhuis C; D'Haens GR; Benninga MA
    J Crohns Colitis; 2021 Jul; 15(7):1106-1113. PubMed ID: 33245332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial.
    Vlieger AM; Menko-Frankenhuis C; Wolfkamp SC; Tromp E; Benninga MA
    Gastroenterology; 2007 Nov; 133(5):1430-6. PubMed ID: 17919634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypnotherapy for irritable bowel syndrome in Saudi Arabian patients.
    Al Sughayir MA
    East Mediterr Health J; 2007; 13(2):301-8. PubMed ID: 17684852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome.
    Lövdahl J; Törnblom H; Ringström G; Palsson OS; Simrén M
    Aliment Pharmacol Ther; 2022 Jun; 55(12):1501-1511. PubMed ID: 35505463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.